INS and liver disorder: FGF1, 19, and 21 have potent (albeit poorly understood) effects on metabolism and insulin signaling, largely through their putative actions in white adipose tissue and the liver [21,41], whereas impaired FGF-receptor signaling is associated with insulin resistance, liver disease [41,42], and impaired hepatic regeneration [43,44].